InMed Pharmaceuticals Inc [INM] stock is trading at $0.25, up 3.28%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INM shares have gain 12.00% over the last week, with a monthly amount glided 21.74%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
InMed Pharmaceuticals Inc [INM] stock has fluctuated between $0.12 and $0.78 over the past year. InMed Pharmaceuticals Inc [NASDAQ: INM] shares were valued at $0.25 at the most recent close of the market.
Analyzing the INM fundamentals
InMed Pharmaceuticals Inc [NASDAQ:INM] reported sales of 4.60M for the trailing twelve months, which represents a drop of -44.48%. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at -0.98%, Pretax Profit Margin comes in at -0.95%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -1.13, Equity is -1.26 and Total Capital is -803.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2378 points at the first support level, and at 0.2235 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2666, and for the 2nd resistance point, it is at 0.2811.
Ratios To Look Out For
For context, InMed Pharmaceuticals Inc’s Current Ratio is 4.41. As well, the Quick Ratio is 3.78, while the Cash Ratio is 3.33. Considering the valuation of this stock, the price to sales ratio is 0.73, the price to book ratio is 0.24.
Transactions by insiders
Recent insider trading involved MANCINI ALEXANDRA DIANE JANET, Consultant, that happened on Jul 31 ’24 when 240.0 shares were sold. Director, HULL ANDREW completed a deal on Feb 21 ’24 to buy 37500.0 shares. Meanwhile, President & CEO ADAMS ERIC A bought 41600.0 shares on Feb 20 ’24.
